Glucose Control vitamins and Herbs.

Glucose Control

DESCRIPTION:
Data suggest that Bitter Melon has a significant 
hypoglycemic effect occurs in both healthy and diabetic 
patients. Glucose control contains well known botanical 
ingredient Mormodica Charantia otherwise known as Bitter Melon. 
Mormodica Charantia (Bitter Melon) contains Glycosides, 
Momordim, Charantin, Polypeptides. Bitter Melon increases 
glucose uptake and glycogen synthesis in the liver, muscle and 
nerve tissue and improves glucose tolerance. Bitter Melon, 
grouped with Fenugreek (another hypoglycemic herb), in 
conjunction with Curcuma Zodoria helps liver cells respond 
quickly, and improves liver function.
 

    * Helps build 
strong immune system
    * Helps build glucose tolerance
    * 
Helps maintain proper blood sugar levels
    * Helps regulate 
lipid metabolism and maintain healthy cholesterol levels
    * 
Helps maintain healthy serum triglyceride levels
    * Helps 
maintain good health


BITTER MELON
A prospective evaluation 
of 18 newly diagnosed adult diabetics comparing blood glucose 
level with and without bitter melon administration 30 minutes 
prior to an oral glucose tolerance test (GTT). Patients had not 
started any hypoglycemic therapy (e.g. insulin or 
sulfonylureas). A statistically significant reduction in blood 
sugar after administration of bitter melon, approximately 
20-30%, was demonstrated. Larger randomized trials are necessary 
to establish long-term effects.

FENUGREEK
A prospective, 
one-arm study of dietary fenugreek in 60 patients with 
non-insulin dependent diabetes of differing severity levels. 40 
patients were taking oral hypoglycemic drugs. Each subject 
underwent 7 days of control diet followed by 24 weeks of 
consuming 25 g/day fenugreek seed powder prepared in a soup. 
Diets in each period were similar in calorie and nutrient 
composition, except for higher fiber content in the fenugreek 
diet. Mean serum cholesterol decreased from baseline (approx. 
241 mg/dl) to 24 weeks (approx. 199 mg/dl), as did LDL 
cholesterol (approx. 143 to 114 mg/dl), LDL+VLDL cholesterol 
(approx. 179 to 148 mg/dl), and triglycerides (approx. 187 to 
159 mg/dl). Diarrhea and flatulence were reported in a few 
patients.

A randomized, controlled, crossover evaluation of 
dietary fenugreek in 10 non-insulin dependent diabetics taking 
glibenclamide, 2.5-7.5 mg/day, with stabilized diet and drug 
dose. The study consisted of two 15-day periods: 5 patients 
received bread containing 25 g fenugreek powder daily for the 
first 15 days, while the other 5 received it in the second 
15-day period. Control bread contained the same nutrient content 
without fenugreek. Food intake and body weight were similar 
between treatment arms. An intravenous glucose tolerance test at 
the end of each period showed significantly lower mean plasma 
glucose levels at 40, 50, and 60 min and an 11% reduction in the 
area under the curve (AUC) in the fenugreek group. Erythrocyte 
insulin receptors were significantly higher in number in the 
fenugreek group. A washout period should have been instituted 
between test periods.

DOSAGE:Two capsules twice daily before 
food